As of 2024-12-11, the Relative Valuation of Inhibrx Inc (INBX) is 2,633.39 USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.97 USD, the upside of Inhibrx Inc based on Relative Valuation is 17491.1%.
The range of the Relative Valuation is 2,181.55 - 3,592.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 31.7x | 26.7x |
| Forward P/E multiples | 19.2x - 20.3x | 19.8x |
| Fair Price | 2,181.55 - 3,592.07 | 2,633.39 |
| Upside | 14472.8% - 23895.1% | 17491.1% |
| Date | P/E |
| 2024-11-29 | 0.13 |
| 2024-11-27 | 0.14 |
| 2024-11-26 | 0.14 |
| 2024-11-25 | 0.13 |
| 2024-11-22 | 0.12 |
| 2024-11-21 | 0.12 |
| 2024-11-20 | 0.12 |
| 2024-11-19 | 0.13 |
| 2024-11-18 | 0.12 |
| 2024-11-15 | 0.12 |
| 2024-11-14 | 0.13 |
| 2024-11-13 | 0.14 |
| 2024-11-12 | 0.15 |
| 2024-11-11 | 0.14 |
| 2024-11-08 | 0.14 |
| 2024-11-07 | 0.14 |
| 2024-11-06 | 0.14 |
| 2024-11-05 | 0.14 |
| 2024-11-04 | 0.14 |
| 2024-11-01 | 0.14 |
| 2024-10-31 | 0.14 |
| 2024-10-30 | 0.14 |
| 2024-10-29 | 0.14 |
| 2024-10-28 | 0.14 |
| 2024-10-25 | 0.14 |
| 2024-10-24 | 0.14 |
| 2024-10-23 | 0.14 |
| 2024-10-22 | 0.14 |
| 2024-10-21 | 0.14 |
| 2024-10-18 | 0.14 |
| 2024-10-17 | 0.14 |
| 2024-10-16 | 0.14 |
| 2024-10-15 | 0.14 |
| 2024-10-14 | 0.14 |
| 2024-10-11 | 0.14 |
| 2024-10-10 | 0.14 |
| 2024-10-09 | 0.14 |
| 2024-10-08 | 0.14 |
| 2024-10-07 | 0.13 |
| 2024-10-04 | 0.13 |
| 2024-10-03 | 0.13 |
| 2024-10-02 | 0.14 |
| 2024-10-01 | 0.14 |
| 2024-09-30 | 0.14 |
| 2024-09-27 | 0.14 |
| 2024-09-26 | 0.14 |
| 2024-09-25 | 0.14 |
| 2024-09-24 | 0.14 |
| 2024-09-23 | 0.14 |
| 2024-09-20 | 0.14 |